Medication info
BILDAVS Tablet 50 mg (Vildagliptin)

BILDAVS Tablet 50 mg (Vildagliptin)

Prescription medicationTabletOral
Ingredient · strength
Vildagliptin›50mg / 1 tablet
Manufacturer / importer
Daewoong Bio Co., Ltd.
Appearance
White to light yellow round tablets
Packaging
30 tablets/Alu-Alu (10 tablets/Alu-Alu*3)
Approval status
Active

MFDS item code 202102288 · Approved 2021.03.15 · Insurance code 694003640

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
- For monotherapy, or when given in combination with metformin in patients who have not previously received antidiabetic drug treatment, administer 50mg once daily in the morning or 100mg per day as 50mg twice daily, in the morning and evening. - When adequate glycemic control cannot be achieved with metformin or thiazolidinedione monotherapy, the recommended dose when this medicine is administered with metformin or a thiazolidinedione is 100mg per day, given as 50mg twice daily, in the morning and evening. - When adequate glycemic control cannot be achieved with sulfonylurea monotherapy, the recommended dose when this medicine is administered with a sulfonylurea is 50mg once daily in the morning. In this patient group, vildagliptin 100mg once daily was not more effective than 50mg once daily. - When adequate glycemic control cannot be achieved with combination therapy of a sulfonylurea and metformin, the recommended dose when this medicine is added (triple therapy) is 100mg per day, given as 50mg twice daily, in the morning and evening. - When adequate glycemic control cannot be achieved with insulin therapy (insulin alone or with metformin), the recommended dose when this medicine is added is 100mg per day, given as 50mg twice daily, in the morning and evening. - This medicine may be taken with or without food. Doses greater than 100mg per day are not recommended. - When this medicine is administered with a sulfonylurea, a reduction in the sulfonylurea dose may be needed to reduce the risk of hypoglycemia. - If you miss a dose, take this medicine as soon as you remember, and take the next dose at the usual time. If you remember close to the time of your next dose, skip the missed dose. Do not take a double dose at one time to make up for a missed dose. Patients with hepatic impairment This medicine is not recommended in patients with hepatic impairment whose ALT or AST levels exceed 2.5 times the upper limit of normal before treatment. Patients with renal impairment - Mild renal impairment (creatinine clearance ≥50mL/min): No dosage adjustment is necessary. - Moderate or severe renal impairment, or end-stage renal disease (ESRD): A dose of 50mg once daily is recommended. (See section 2 under ‘3. General Precautions’ in Precautions for Use)

Ingredients

Manufacturer
Daewoong Bio Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Blood sugar control disorder in type 2 diabetes patients
View approved original text

This medication is used as an adjunct to diet and exercise to improve blood sugar control in patients with type 2 diabetes. It can be administered alone or in combination with other medications. This helps effectively manage blood sugar levels.

How to take

Adult dose

- For monotherapy, or when given in combination with metformin in patients who have not previously received antidiabetic drug treatment, administer 50mg once daily in the morning or 100mg per day as 50mg twice daily, in the morning and evening. - When adequate glycemic control cannot be achieved with metformin or thiazolidinedione monotherapy, the recommended dose when this medicine is administered with metformin or a thiazolidinedione is 100mg per day, given as 50mg twice daily, in the morning and evening. - When adequate glycemic control cannot be achieved with sulfonylurea monotherapy, the recommended dose when this medicine is administered with a sulfonylurea is 50mg once daily in the morning. In this patient group, vildagliptin 100mg once daily was not more effective than 50mg once daily. - When adequate glycemic control cannot be achieved with combination therapy of a sulfonylurea and metformin, the recommended dose when this medicine is added (triple therapy) is 100mg per day, given as 50mg twice daily, in the morning and evening. - When adequate glycemic control cannot be achieved with insulin therapy (insulin alone or with metformin), the recommended dose when this medicine is added is 100mg per day, given as 50mg twice daily, in the morning and evening. - This medicine may be taken with or without food. Doses greater than 100mg per day are not recommended. - When this medicine is administered with a sulfonylurea, a reduction in the sulfonylurea dose may be needed to reduce the risk of hypoglycemia. - If you miss a dose, take this medicine as soon as you remember, and take the next dose at the usual time. If you remember close to the time of your next dose, skip the missed dose. Do not take a double dose at one time to make up for a missed dose. Patients with hepatic impairment This medicine is not recommended in patients with hepatic impairment whose ALT or AST levels exceed 2.5 times the upper limit of normal before treatment. Patients with renal impairment - Mild renal impairment (creatinine clearance ≥50mL/min): No dosage adjustment is necessary. - Moderate or severe renal impairment, or end-stage renal disease (ESRD): A dose of 50mg once daily is recommended. (See section 2 under ‘3. General Precautions’ in Precautions for Use)

Precautions

This medication should not be used in patients with allergic reactions, type 1 diabetes, or diabetic ketoacidosis. It should also not be administered to patients with inherited lactose intolerance. Abnormal liver function may occur rarely during treatment, so it is important to undergo regular liver function tests before and during treatment. If symptoms of liver dysfunction occur, consult a doctor immediately, and in severe cases, treatment should be discontinued. This medication does not replace insulin therapy and should be used cautiously in patients with very poor kidney function. Experience regarding its use in heart failure patients is limited, so caution is needed and it is not recommended for severe heart failure patients. If symptoms such as blisters or ulcers appear on the skin during use, inform healthcare providers immediately. There is a risk of acute pancreatitis, so if symptoms such as abdominal pain, nausea, or vomiting occur, seek medical attention immediately. The risk of hypoglycemia may increase when used with other diabetes medications that can cause hypoglycemia, so dose adjustment may be necessary. If symptoms such as dizziness occur, it is advisable to avoid driving or operating machinery. Severe joint pain may occur, and if pain is severe, consider discontinuation of the medication. Its safety in pregnant and breastfeeding women has not been established, so it is advisable not to use it. There is no need for special dose adjustment in the elderly, and it is not recommended for children and adolescents under 18 years of age. In case of overdose, there is no specific antidote, and supportive treatment based on symptoms is required. The medication is not effectively removed by dialysis. This medication should be kept out of the reach of children and should not be transferred to another container.

Side effects

  • Hepatitis
  • impaired liver function
  • elevated transaminase levels
  • angioedema
  • tremors
  • headache
  • dizziness
  • fatigue
  • nausea
  • hypoglycemia
Show 55 more
  • pharyngitis
  • weakness
  • constipation
  • weight gain
  • peripheral edema
  • gastroesophageal reflux
  • diarrhea
  • bloating
  • chills
  • decreased blood sugar
  • sweating
  • pancreatitis
  • urticaria
  • blisters
  • exfoliative skin lesions
  • severe arthralgia
  • cutaneous vasculitis
  • cholecystitis
  • upper respiratory tract infection
  • lip blisters
  • dry mouth
  • vomiting
  • insomnia
  • dyspepsia
  • renal impairment
  • drowsiness
  • chest discomfort
  • hunger
  • sensory loss
  • spinal stenosis
  • abdominal pain
  • gastroenteritis
  • gastritis
  • gastric ulcer
  • belching
  • appendicitis
  • fatty liver
  • hyperkalemia
  • hypertriglyceridemia
  • heart failure
  • cardiomegaly
  • angina
  • cardiac arrest
  • renal cyst
  • lung carcinoma
  • leg pain
  • increased C-reactive protein
  • myalgia
  • paresthesia
  • fever
  • edema
  • elevated creatine phosphokinase
  • elevated AST
  • elevated C-reactive protein
  • increased myoglobin levels

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture, so it should be stored in a tightly closed container. Additionally, it should be kept in a cool place below 30 degrees Celsius to maintain its efficacy.

Appearance and packaging

Appearance

White to light yellow round tablets

Package unit

30 tablets/Alu-Alu (10 tablets/Alu-Alu*3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.